4.8 Article

Three-Dimensional Inverse Opal Photonic Crystal Substrates toward Efficient Capture of Circulating Tumor Cells

期刊

ACS APPLIED MATERIALS & INTERFACES
卷 9, 期 36, 页码 30510-30518

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acsami.7b10094

关键词

circulating tumor cells (CTCs); inverse opal photonic crystal (IOPC); nanostructure; detection and isolation; enhancing fluorescence signal

资金

  1. National Key Research and Development Program [2016YFC0207101]
  2. Major State Basic Research Development Program of China (973 Program) [2014CB643506]
  3. National Natural Science Foundation of China [11374127, 21403084, 11674126, 11674127, 11504131, 61674067]
  4. Jilin Province Natural Science Foundation of China [20150520090JH, 20170101170JC]
  5. Jilin Province Science Fund for Excellent Young Scholars [20170520129JH, 20170520111JH]

向作者/读者索取更多资源

Artificial fractal structures have attracted considerable scientific interest in circulating tumor cells (CTCs) detection and capture, which plays a pivotal role in the diagnosis and prognosis of cancer. Herein, we designed a bionic TiO2 inverse opal photonic crystal (IOPC) structure for highly efficient immunocapture of CTCs by combination of a magnetic Fe3O4@C-6@silane nanoparticles with anti-EpCAM (antiepithelial cell adhesion molecule) and microchannel structure. Porous structure and dimension of IOPC TiO2 can be precisely controlled for mimicking cellular components, and anti-EpCAM antibody was further modified on IOPC interface by conjugating with polydopamine (PDA). The improvement of CTCs capture efficiency reaches a surprising factor of 20 for the IOPC interface compared to that on flat glass, suggesting that the IOPCs are responsible for the dramatic enhancement of the capture efficiency of MCF-7 cells. IOPC substrate with pore size of 415 nm leads to the optimal CTCs capture efficiency of 92% with 1 mL/h. Besides the cell affinity, IOPCs also have the advantage of light scattering property which can enhance the excitation and emission light of fluorescence labels, facilitating the real-time monitoring of CTCs capture. The IOPC-based platform demonstrates excellent performance in CTCs capture, which will take an important step toward specific recognition of disease-related rare cells.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据